WU
54
-2
BIIB
66
3
DE
49
-4
DVA
38
-3
FSLR
49
-23
VRSK
32
-5
PEP
29
-3
VMC
68
-4
MAT
72
3
SBUX
43
-4
ZBH
62
-6
PVH
39
-5
EXR
31
-4
NEE
46
-8
AON
54
2
FLS
61
-3
CSCO
53
-3
MCK
69
-2
BK
75
-2
NKE
33
-17
WU
54
-2
BIIB
66
3
DE
49
-4
DVA
38
-3
FSLR
49
-23
VRSK
32
-5
PEP
29
-3
VMC
68
-4
MAT
72
3
SBUX
43
-4
ZBH
62
-6
PVH
39
-5
EXR
31
-4
NEE
46
-8
AON
54
2
FLS
61
-3
CSCO
53
-3
MCK
69
-2
BK
75
-2
NKE
33
-17
Financhill
Back

iShares BB Rated Corporate Bond ETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison

Sell
45

HYBB
iShares BB Rated Corporate Bond ETF

Last Price:
$47.21
Seasonality Move:
-1.04%
Buy
75

DRUG
Bright Minds Biosciences, Inc.

Last Price:
$90.03
Seasonality Move:
-24.59%
Sell
45
iShares BB Rated Corporate Bond ETF (HYBB) is a Sell

Is iShares BB Rated Corporate Bond ETF a Buy, Sell or Hold?

  • The current iShares BB Rated Corporate Bond ETF [HYBB] share price is $47.24. The Score for HYBB is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • HYBB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Bright Minds Biosciences, Inc. (DRUG) is a Buy

Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?

  • The current Bright Minds Biosciences, Inc. [DRUG] share price is $95.99. The Score for DRUG is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • DRUG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

HYBB Stock Price Chart

What is iShares BB Rated Corporate Bond ETF's stock price today?

  • The iShares BB Rated Corporate Bond ETF share price today is $47.24
    The current trend is relatively stagnant and HYBB is experiencing selling pressure, which indicates risk of future bearish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences, Inc.'s stock price today?

  • The Bright Minds Biosciences, Inc. share price today is $95.99
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.

HYBB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 56.27 Buy
Chaikin Money Flow: -9892 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.03 - 47.21) Buy
Bollinger Bands (100): (46.95 - 47.27) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.7 Buy
Relative Strength Index (14 RSI): 65.61 Buy
Chaikin Money Flow: 292843 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (74.33 - 88.51) Buy
Bollinger Bands (100): (45.68 - 74.86) Buy

HYBB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.17 Buy
20-day SMA: 47.11 Buy
50-day SMA: 47.11 Buy
200-day SMA: 46.68 Buy
8-day EMA: 47.18 Buy
20-day EMA: 47.13 Buy
50-day EMA: 47.1 Buy
200-day EMA: 46.83 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 83.5 Buy
20-day SMA: 83.91 Buy
50-day SMA: 69.69 Buy
200-day SMA: 45.45 Buy
8-day EMA: 85.95 Buy
20-day EMA: 81.76 Buy
50-day EMA: 72.81 Buy
200-day EMA: 51.04 Buy

iShares BB Rated Corporate Bond ETF Earnings Growth & HYBB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.93 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.27 per share, and a decrease next year of $1.59 per share.

iShares BB Rated Corporate Bond ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):